Top Markets
#1 ADO Protocol ADO Protocol +195.93%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +59.90%
#4 Starpower Starpower +25.21%
#5 GAIB AID GAIB AID +24.67%
#6 Casper Network Casper Network +15.83%
#7 The Black Bull The Black Bull +14.10%
#8 Verus Coin Verus Coin +13.54%
#9 Status Status +12.46%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +10.19%
Coin of the day
ADO Protocol ADO Protocol
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Chembio Diagnostics, Inc. Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc.

CEMI
Pozycja w akcjach #33418
Chembio Diagnostics, Inc., along with its subsidiaries, specializes in... Chembio Diagnostics, Inc., along with its subsidiaries, specializes in creating, producing, and bringing to market point-of-care (POC) diagnostic tests used for identifying and diagnosing various diseases. Their current product offerings include tests for critical conditions like COVID-19, HIV/Syphilis, and the Zika virus. Beyond these, the company is dedicated to advancing diagnostics for a wide array of other infectious diseases, such as malaria, dengue, chikungunya, Chagas disease, Ebola, leishmaniasis, Lassa fever, Marburg virus, leptospirosis, rickettsia, and Burkholderia infections. These diagnostic tools are sold under well-known brand names including STAT-PAK, SURE CHECK, STAT VIEW, and DPP. Chembio distributes its products directly and through various partners to a diverse global customer base. This clientele includes medical laboratories, hospitals, government and public health agencies, non-governmental organizations (NGOs), medical professionals, and retail outlets across the United States and worldwide. The company engages in strategic partnerships with prominent organizations such as the Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics. Additionally, Chembio collaborates with several key U.S. government entities, including the Centers for Disease Control and Prevention (CDC), the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture (USDA). Founded in 1985, Chembio Diagnostics, Inc. has its headquarters located in Hauppauge, New York.
Cena akcji
$0.455
Ostatnia synchronizacja: 2023-04-27
Kapitalizacja rynkowa
$7.70M
Zmiana (1 dzień)
0.22%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Chembio Diagnostics, Inc. (CEMI)

Kategoria

Healthcare
Historia stopy dywidendy dla Chembio Diagnostics, Inc. (CEMI)
Stopa dywidendy (TTM) dla Chembio Diagnostics, Inc. (symbol akcji: CEMI) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Chembio Diagnostics, Inc. (CEMI) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
0.31%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
0.71%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
0.00%
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
0.00%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
0.00%
US